Discontinuation report ALOXI
Report ID | 12727 |
Drug Identification Number | 02381710 |
Brand name | ALOXI |
Common or Proper name | Aloxi |
Company Name | KNIGHT THERAPEUTICS INC. |
Market Status | MARKETED |
Active Ingredient(s) | PALONOSETRON |
Strength(s) | 0.25MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 0.25 mg/5 mL |
ATC code | A04AA |
ATC description | ANTIEMETICS AND ANTINAUSEANTS |
Reason for discontinuation | Other (Please describe in comments) |
Anticipated discontinuation date | 2017-06-13 |
Actual discontinuation date | 2017-06-13 |
Remaining supply date | 2017-06-13 |
Discontinuation status | Reversed |
Discontinuation decision reversal | Yes |
Information on remaining supply | |
Company comments | Purdue Pharma is discontinuing the intravenous solution. IV formulations of other 5HT3s are available in Canada. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3400 DE MAISONNEUVE BLVD W MONTREAL, QUEBEC CANADA H3Z 3B8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2017-09-21 | French | Compare |
v6 | 2017-09-21 | English | Compare |
v5 | 2017-09-21 | English | Compare |
v4 | 2017-06-14 | English | Compare |
v3 | 2017-06-13 | French | Compare |
v2 | 2017-06-13 | English | Compare |
v1 | 2017-06-13 | English | Compare |
Showing 1 to 7 of 7